A designer is a human embryo that has been genetically modified , usually following guidelines set by the parent or scientist, to produce desirable traits. This is done using various methods, such as gene therapy or Preimplantation genetic diagnosis (PGD). This technology is the subject of ethical debate, bringing up the concept of genetically modified “superhumans” to replace modern humans.
Preimplantation genetic diagnosis
In medicine and (clinical) genetics pre-implantation genetic diagnosis (PGD or PIGD) (also known as embryo screening ) is a procedure performed on embryos prior to implantation , sometimes even on oocytes prior to fertilization . The methods of PGD help to identify and locate genetic defects in early embryos have been conceived through in vitro fertilization (IVF).  The IVF procedure is carried out by the removal of one or two cells when the embryo is at a specific stage in development. The PGD uses the technology to obtenir IVF oocytes or embryos for evaluation of the organism’s genome.
The PGD procedures enable the identification of orphan diseases in the oocytes or embryos by using in-situ hybridization (ISH).  The ISH technical labels specific nucleic acid sequences can be used to detect genetic abnormalities. 
Conversely, this technique can also help select for desirable traits by avoiding implanting embryos with genes that have serious diseases or disabilities. Examples of desirable traits that could be selected would be increased muscle mass, voice pitch, or high intelligence. Overall, the procedure of PGD to select for a positive trait is referred to the creation of a “baby designer”. 
This is a new technology – the first PGD babies, and thus also the first designer were born in 1989 and born in 1990. 
A 2012 article by Carolyn Abraham in The Globe and Mail stated that “Recent breakthroughs have made it possible to scan every chromosome in a single embryonic cell, to test for genes involved in ‘conditions,’ some of which are clearly life-threatening while others are less dramatic and less certain “. There is already a ” microchip That can test 1,500 remarkable genetic traits at once, Including heart disease , emotional seasonal disorder , obesity , Athletic Ability, hair and eye color , height , susceptibility to alcohol and nicotineaddictions, lactose intolerance and one of several genes linked to intelligence . It is still difficult to get enough DNA for such extensive testing but the chip designer thinks this technical problem will be solved soon. 
Regulation of Preimplantation Genetic Diagnosis
PGD has been used primarily for medical purposes, but the possibilities of the procedure increase the idea of non-medical uses. Non-medical motives could lead to potential problems when trying to make the distinction of when the procedure is needed or desired.
For example, PGD has the ability to select an embryo based on gender preferences (Stankovic). Since this is not needed, but desired this could cause much controversy. Additionally, the procedure is able to create a donor offspring or a “savior sibling”, which can assist a pre-existing offspring for medical purposes.  The “savior sibling” is a brother or sister who is created to donate life-saving tissue to an existing child. There have been arguments against the procedures of “savior siblings” because many believe that this will lead humans to the creation of designer babies. For example, one critic said, “the new technique is a dangerous first step towards allowing parents to use embryo testing to choose other characteristics of the baby, such as eye color and sex”. 
The artificial selection of traits through the use of PGD has become widely accepted.
Many countries completely prohibit PGD, including Austria , Germany , Ireland , and Switzerland . Other countries restrict PGD to medical use only, including Belgium , France , Greece , Netherlands , Italy , Norway , and the United Kingdom .
In contrast, the United States federal law does not include any regulation of PGD. Those who are in favor of PGD believe the government should not be involved in the procedure and parents should have a reproductive choice. The opponent has argued that PGD will allow embryo selection based on trivial traits. While other critics believe that this procedure could lead to a new form of Eugenics . 
The regulation of PGD has become an important topic, however much of the artificial trait selection remains only prospective until technology advances. For example, scientist do not know which specific is associated with specific features, like voice pitch or intelligence. Nevertheless, with the current rate of advancements, it is believed that the future will exist. 
Genetic engineering of human gametes, zygotes, or embryos (aka germline modification)
The other use for designer babies Concerns as possible uses of gene therapy technology to create Desired traits of a child, Such As disease resistance, sex, hair color and other cosmetic features, Athletic Ability, and intelligence. 
Understanding of genetics for human traits
This section needs expansion . You can help by adding to it .(December 2012)
Genetics explains the process of parents passing down certain genes to their children. Genes are inherited from both biological parents, and each gene expresses a specific trait. The traits expressed by genes can be seen as such, color, eye color, or height can be 
Human genes are found within chromosomes. Humans have 23 pairs of chromosomes, 46 individual chromosomes. 23 chromosomes are inherited from the father, and 23 from the mother. Each chromosome can carry about 20,000 genes. 
Researchers have already connected the genes in the stripes to the color of the skin.  Many other things could be discovered in further years with the new possibilities of cloning animals.
Scientists have been able to understand the genetic traits of humans through human genome projects . This project was launched around 1990 and was an international research project that had an end goal of mapping and understanding every gene in the human body.  As a part of the Human Genome Project, we have been able to pinpoint specific locations for about 12,800 specific genes within different chromosomes. 
Germline modification has been around since the 1980s, as there have been successful animal trials dating back to that time.  In order for germline modification to be successful, medical professionals must know how to Introduce a gene into the patient’s’ cell and the germline so That It Will Be Transferred subsequent generations and still Maintain the proper functionality.  The way in which genes are integrated into the DNA is what determines the difference between germline modification and somatic cell modification.  In order to be transferred to succeed generations, these changes are carried out by the development of germ cells . Changes in the germline result in permanent and heritable changes to the DNA.  While amplification of positive effects would occur, there is also the risk that amplification of possible negative effects would also occur.  Since the results are generational, it is not a simple task to figure out if the benefits of germination change outweigh the harm.  Allowing families to have the ability to design their children is more important than germline modification presents. 
Germline modification can be accomplished through different techniques that focus on the modification of the germinal epithelium [ disambiguation needed ] , germ cells , or the fertilized egg .  Most of the techniques include transporting transgenes and then transgenes are integrated with the DNA of the zygote.  After integration, the transgene becomes a stable and functioning portion of the host’s genome.  One technique involves a specific sequence of cloned DNA being inserted into the fertilized egg using microinjection technique. The sequence in inserted directly into the pronucleus. The second technique uses the transfection process. Stem cells obtained from the embryo during the blastocysts are modified, combined with naked DNA , and the resulting cells are kidneys into the embryo that is developing.  The third technique focuses on carrying DNA into the embryo by using retroviruses . 
Feasibility of gene therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. Gene therapy was first conceptualized in 1972, with the authors urging caution before starting gene therapy studies in humans.  The first FDA-approved gene therapy experiment in the United States occurred in 1990, a four-year-old girl named Ashanti DeSilva, who was treated for ADA – SCID .   This is a disease that has left her defenseless against spreading infections throughout her body. Dr. W Anderson Anderson was a major lead on this clinical trial, he worked for the National Heart, Lung, and Blood Institute Since then, over 1,700 clinical trials have been conducted using a number of techniques for gene therapy. 
Techniques in Gene Therapy
The techniques used in gene therapy, which are also referred to as vectors, have a method of using a healthy gene to attack and replace an infected gene. The amount of techniques or vectors that have been used to conduct these clinical trials vary. A few of the techniques are basic processing, gene doping , and viral vectors . Viral infections can be life-threatening in patients who are immune-compromised because they can not mount an effective immune response. T cell-based immunotherapy, stem-cell-based therapy, genetic vaccines, and other approaches to genetic blockade of infection.  There are also known approaches, Cell-Based Approaches, Cell Therapy, Stem-Cell-Based Approaches, and Genetic Vaccines.
Basic processing can be achieved by replacing a mutated gene, the inactivation of a mutated gene, or the introduction of a new gene to help a disease caused by mutation. Secondly, gene doping is a procedure of gene therapy modulates gene expression of a particular gene. This procedure is mainly used to improve athletic ability for sporting events. This is a genetic form of human enhancement that is able to treat muscle-wasting disorders. It is a highly controversial procedure because the results are not so unusual to the bloodstream, so athletic officials would be unable to detect chemicals in a blood or urine test. An example of gene doping would be proving athlete with erythropoietin(EPO) is a hormone that increases blood cell count. Lastly, viral vectors are able to mimic the methods of a normal virus in the human body to include ‘good’ genes into a human cell. For instance, scientists are able to positively change the host’s genome by removing the genes that cause disease and replace it with genes of the desired trait (“Types of Gene Therapy”).
The techniques have been used by scientist, but the most popular techniques are Naked DNAand DNA complex. The injection of the Naked DNA is the simplest method of the vector delivery method. The Naked DNA is a histone-free, modified DNA sequence that removes proteins that would normally surround it. This form of delivery is sometimes used as a natural compound, but the United States has made a wide range of synthetic compounds for gene delivery. The other form, which is DNA Compounds, has been used when compounded with a chemical compound in order to produce the desired compound. There are other studies that are currently under way that have been referred to as the hybrid method because there is a combination of two or more gene therapy techniques. This can be the idea that the desired gene will stick during the delivery, transfer, and implant.
The manipulation of an organism’s genome for a desirable trait is related to the medical procedure of cloning . The process of cloning results in making genetically identical organisms. Moreover, scientists can use gene therapy vectors to modify the DNA to be unique to a particular organism. Moreover, the techniques established by the field of gene therapy can be used to create “designer babies”. This can be achieved through the use of IVF to assist in creating a genetically designed baby.
Disease Control in Gene Therapy
Gene therapy is being studied for the treatment of a wide variety of acquired and inherited disorders. Retroviruses, adenoviruses, poxviruses, adenoviruses poxviruses, herpesviruses, and others are being engineered to gene therapy vectors and are being administered to patients in a clinical setting.  Some of the other genetic disorders That can be tried in a clinical trial are ADA-SCID , have qui Stated Earlier, is Severe Combined Immune Deficiency, CGD qui est Chronic Granulomatous Disorder , and Hemophilia. These examples of disorders are only a few among a number of others that are being discovered. Some of the diseases that can be controlled in a clinical trial with cancer and neurodegenerative diseases such as Parkinson ‘s Disease or Huntington’ s Disease . 
Ethics and risks
Lee Silver has projected a dystopia in which a race of superior humans look down on those without genetic enhancements, though others have counseled against accepting this vision of the future.  It has been suggested that genetic engineering has been created by genetic engineering, which may have deleterious effects on the human gene pool.  Some futurists claim that it would be possible for the human species to evolve.   It has also been argued that the designer may have an important role as counter-acting anecdotal dysgenic trend. 
There are risks associated with genetic modifications to any organism. When focusing on the ethics of this treatment, medical professionals and clinical ethicists take many factors into consideration. They look at whether or not the goal and outcome of the treatment is an individual impact and their family lineage or a group of people.  The main ethical issue with pure germline change is that these types of treatments will be changed and will be passed down to future generations and therefore any known or unknown, will also be passed down and will affect the offspring.  New diseases may be introduced accidentally.  
The use of germline modification is justified when it is used to correct genetic problems that can not be treated with somatic cell therapy, stabilize DNA in a mating that has the potential to be high risk, provide an alternative to the abortion of embryos that genetically problematic for a family, and intensify the incidence of genes that are favorable and desirable.  This can lead to perfected lineages on a genotypic level and possibly a phenotypic level. Ultimately, these issues raised potential questions about the welfare and identity of individuals that have been genetically modified through the germline. 
Safety is a major concern when it comes to the gene editing and mitochondrial transfer. Since the effects of germination can be passed down to multiple generations, this problem has been investigated.  If a patient has undergone germline modification treatment, the coming generations, one or two after the initial treatment, will be used as successful trials.  This study has been carried out for a number of years. Problems with the gene editing may not appear until after the child. If the patient assumes the risk alone, it is possible to give consent for the treatment.  A larger scale has the potential to impact the gene pool of the human race in a negative or positive way.  Germline modification is considered ethically and morally acceptable when a patient is a carrier for a harmful trait and is treated to improve the genotype and safety of the future generations.  When the treatment is used for this purpose, it can fill the gaps that other technologies may not be able to accomplish. 
Since experimentation of the germline occurs directly on embryos, there is a major ethical problem with fertilizing eggs and embryos and killing the flawed ones.  The embryo can not give consent and some of the treatments have long-lasting and harmful implications.  In many countries, editing embryos and germline modification for reproductive use is illegal.  As of 2017, the United States of America restricts the use of germline modification and the procedure is under heavy regulation by the FDA and NIH .  The American National Academy of Sciences and the National Academy of Medicine”but only for serious conditions under stringent oversight.”  Germline modification would be more practical if sampling methods were less destructive and used rather than embryos. 
- Directed evolution (transhumanism)
- Human enhancement
- Human genetic engineering
- Eugenics in the United States
- Genetically modified organism
- Germinal choice technology
- Human Germline Engineering
- ^ Jump up to:a b Stankovic, Bratislav (2005-02-07). ” ‘ It’s a Designer Baby!’ – Opinions on Regulation of Preimplantation Genetic Diagnosis “. Rochester, NY: Social Science Research Network. SSRN 1756573 .
- ^ Jump up to:a b c d Walker, Mark (2008). “Designer babies and Harm to Supernumerary Embryos”. American Philosophical Quarterly . 45.4 : 349-364.
- Jump up^ Bishop, Ryan (2010). “Applications of Fluorescence in Situ Hybridization (FISH) in Detecting Genetic Aberrations of Medical Significance”. Bioscience Horizons . 3.1 : 85-95.
- Jump up^ Handyside AH, Kontogianni EH, Hardy K, Winston RM (1990). “Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification”. Nature . 344 (6268): 768-70. doi : 10.1038 / 344768a0 . PMID 2330030 .
- Jump up^ Carolyn Abraham,Unnatural Selection: Is Evolving reproductive technology ushering in a new age of eugenics? , January 07, 2012, The Globe and Mail
- Jump up^ Sheldon, S .; Wilkinson, S. (2004-12-01). “Should selecting savior siblings be banned?” . Journal of Medical Ethics . 30 (6): 533-537. doi :10.1136 / jme.2003.004150 . ISSN 1473-4257 . PMC 1733988 . PMID 15574438 .
- Jump up^ “BBC NEWS | Health | Pro-life challenge to embryo testing” . news.bbc.co.uk . Retrieved 2016-12-08 .
- Jump up^ Gordon JW (1999). “Genetic enhancement in humans”. Science . 283(5410): 2023-4. Bibcode : 1999Sci … 283.2023G . doi : 10.1126 / science.283.5410.2023 . PMID 10206908 .
- ^ Jump up to:a b c “What is Genetics?” . News-Medical.net . 2009-12-11 . Retrieved 2016-11-15 .
- ^ Jump up to:a b Green, Ronald M. (2007). Babies By Design: The Ethics of Genetic Choice . New Haven: Yale University Press. pp. 96-97. ISBN 978-0-300-12546-7 . 129 954 761.
- Jump up^ “An Overview of the Human Genome Project – National Human Genome Research Institute (NHGRI)” . www.genome.gov . Retrieved 2016-09-27 .
- ^ Jump up to:a b c d e f Smith, Kevin R .; Chan, Sarah; Harris, John. “Human Germline Genetic Modification: Scientific and Bioethical Perspectives” . Archives of Medical Research . 43 (7): 491-513. doi : 10.1016 / j.arcmed.2012.09.003 .
- ^ Jump up to:a b Anderson, W. French (1985-08-01). “Human Gene Therapy: Scientific and Ethical Considerations” . Journal of Medicine and Philosophy . 10(3): 275-292. doi : 10.1093 / jmp / 10.3.275 . ISSN 0360-5310 . PMID 3900264 .
- ^ Jump up to:a b c d e f g h i j k l m n o Lappé, Marc (1991-12-01). “Ethical Issues in Manipulating the Germ Line” . Journal of Medicine and Philosophy . 16(6): 621-639. doi : 10.1093 / jmp / 16.6.621 . ISSN 0360-5310 . PMID 1787391 .
- ^ Jump up to:a b c d Dresser, Rebecca (2008-01-01). Gordijn, Bert; Chadwick, Ruth, eds. Medical Enhancement and Posthumanity . The International Library of Ethics, Law and Technology. Springer Netherlands. pp. 191-205. doi : 10.1007 / 978-1-4020-8852-0_12 . ISBN 9781402088513 .
- Jump up^ “Gene therapy for human genetic disease?”. Science . 178 (4061): 648-9. 1972. Bibcode : 1972Sci … 175..949F . doi : 10.1126 / science.178.4061.648 . PMID 4343766 .
- Jump up^ Sheridan, C. (2011). Gene therapy finds its niche. Nature Publishing Group, 29 (2), 121-128. Nature Publishing Group. doi:10.1038 / nbt.1769
- Jump up^ “Gene Therapy” .
- Jump up^ “Gene Therapy – A Revolution in Progress: Human Genetics and Medical Research” . history.nih.gov . Retrieved 2016-12-08 .
- Jump up^ J. Gene Med. Gene Therapy Clinical Trials Database.
- Jump up^ “Gene Therapy for Diseases | ASGCT – American Society of Gene & Cell Therapy” . www.asgct.org . Retrieved 2016-12-08 .
- Jump up^ Evans, Martin E .; Lesnaw, Judith A. (2002-09-01). “Infection Control for Gene Therapy: A Busy Physician’s Primer” . Clinical Infectious Diseases . 35 (5): 597-605. doi : 10.1086 / 342194 . ISSN 1058-4838. PMID 12173136 .
- Jump up^ “Gene Therapy for Disease” .
- ^ Jump up to:a Silver B , Lee M. (1998). Remaking Eden: Cloning and Beyond in a Brave New World . Harper Perennial. ISBN 0-380-79243-5 .
- Jump up^ Baird, Stephen L. (April 2007). “Designer Babies: Eugenics Repackaged or Consumer Options?” (PDF) . Technology Teacher . 66 (7): 12-16. Archived from the original on March 28, 2014.
- Jump up^ Hughes, James (2004). Citizen Cyborg : Why Democratic Societies Must Respond to the Redesigned Human of the Future . Westview Press. ISBN 0-8133-4198-1 .
- Jump up^ Lynn, Richard; Harvey, John (2008). “The decline of the world’s IQ”. Intelligence . 36 (2): 112-20. doi : 10.1016 / j.intell.2007.03.004 .
- Jump up^ Agar, Nicholas (2006). “Designer Babies: Ethical Considerations” . ActionBioscience.org .
- Jump up^ Pang, Ronald TK (January 2016). “Designer babies”. Obstetrics, gynecology and reproductive medicine . 26 (2): 59-60. doi : 10.1016 / j.ogrm.2015.11.011 .
- ^ Jump up to:a b Ishii, Tetsuya. “Germline genome-editing research and its socioethical implications” . Trends in Molecular Medicine . 21 (8): 473-481. doi : 10.1016 / j.molmed.2015.05.006 .
- Jump up^ Harmon, Amy (2017-02-14). “Human Gene Editing Receives Science Panel Support” . The New York Times . ISSN 0362-4331 . Retrieved 2017-02-17 .